Digital Pathology Market Segmented On The Basis Of Product, Application, End Use, Region And Forecasts 2027

06/apr/2020 14:01:20 Grand View Research Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Digital Pathology Market

San Francisco, 6  April 2020: The Report Digital Pathology Market Size, Share & Trends Analysis Report By Product, By Application (Drug Discovery & Development, Academic Research, Diagnosis), By End Use (Hospitals, Clinics), And Segment Forecasts, 2020 – 2027

The global digital pathology market size is expected to reach USD 1.86 billion by 2027, registering a CAGR of 11.8% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Technological advancements, such as digital imaging, computerization, robotic light microscopy, and multiple fiberoptic communications are some of the key factors driving the adoption of digital pathology. In addition, introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Digital pathology has important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel adoption of the technology over the forecast period.

The market is expected to witness intense competition in near future owing to rising adoption of rigorous strategies by the market players to sustain competition. For instance; whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture greater revenue share.

Access Research Report of Digital Pathology Market

Recent Developments In The Digital Pathology Market

  • Inspirata acquired Omnyx LLC from GE Healthcare in January 2018, providing the former with the most comprehensive digital pathology workflow solution globally through the presence of an end-to-end integrated pathology solution, while also providing the company with a fully supported IVD device that would help in digital diagnosis in Canada and Europe.
  • NantHealth, in partnership with NantOmics, launched a unique AI platform to aid pathologists in image-based lung cancer subtyping, in January 2020. The development would help in improving methods for identifying tumor infiltrating white cells.
  • Sectra announced a digital pathology contract with Zuyderland FC in January 2020, which would allow easier exchange and access of image and information between hospitals and departments.
  • Roche and GE launched their first product in May 2019, called the ‘NAVIFY Tumor Board 2.0’, which accumulates data from medical imaging and diagnostic tests, thus allowing cancer teams to have a comprehensive view of each patient.
  • The Philips Pathology SDK was launched in August 2019, which would allow access of pathology image data to research scientists and software developers. This would open new opportunities for data mining and visualization, as well as histopathology image processing.

Access Press Release of Digital Pathology Market @


blog comments powered by Disqus è un servizio offerto da Factotum Srl